This theory should be verified by physiological liver data in future studies, but it is supported by Behari et al., who associated inhibited beta-catenin signalling with defective cholesterol homeostasis and increased hepatic cholesterol accumulation and steatosis [52]. Here, CTNNB1 is linked to steatosis.